Tickets – Health Industry Hub Awards 2026

BOOK YOUR TICKETS

Reserve your tickets to the Health Industry Hub Catalysts for Change Awards to join your colleagues and peers in celebrating the remarkable individuals and organisations that inspire us to challenge the status quo and embark on a purposeful journey to reimagine healthcare.

Date: Thursday, 5 November 2026
Time: 6pm – 10pm
Venue: Dockside – The Balcony Level, Cockle Bay Wharf, Darling Harbour

We’re counting down to a night of celebration with you and your team. Please book your tickets by 23 October.💫

Price: $ 428.00
Price: $ 3,850.00
Name(Required)
Billing Address(Required)
First name, surname and email

No refunds are issued once tickets have been purchased. If you have any questions, please contact us here.

News - MedTech & Diagnostics

Roche unlocks new horizons for genomic research in Asia Pacific

Roche unlocks new horizons for genomic research in Asia Pacific

Health Industry Hub | November 9, 2026 |

Roche is advancing its next-generation sequencing (NGS) ambitions in Asia Pacific following the global launch of AXELIOS 1 in June […]

More


News - Pharmaceuticals

'Unexpected and Surprising': Novartis’ Lp(a) setback raises tough questions for Amgen and Lilly - Professor Stephen Nicholls, Victorian Heart Hospital

‘Unexpected and surprising’: Novartis Lp(a) setback raises tough questions for Amgen and Lilly

Health Industry Hub | November 9, 2026 |

The failure of Novartis’ lipoprotein(a) [Lp(a)] therapy to translate substantial biomarker reductions into meaningful cardiovascular benefits has been met with […]

More


News - MedTech & Diagnostics

More public hospitals turn to same-day hip and knee surgery but recovery risks persist

More public hospitals turn to same-day hip and knee surgery, but key blind spots persist

Health Industry Hub | November 9, 2026 |

Same-day hip and knee replacements to ease surgical waiting lists are being trialled at The Royal Adelaide Hospital (RAH), but […]

More


News - Pharmaceuticals

TGA approves oral Wegovy, prompting questions over efficacy and clinical positioning

TGA approves oral Wegovy, prompting questions over efficacy and clinical positioning

Health Industry Hub | November 9, 2026 |

The Therapeutic Goods Administration (TGA) approval of Novo Nordisk’s oral GLP-1 receptor agonist Wegovy (semaglutide) is introducing a new dimension to […]

More


This content is copyright protected. Please subscribe to gain access.